Abstract
Ocrelizumab (Ocrevus (R)) is a humanized anti-CD20 monoclonal antibody approved for the treatment of adults with relapsing multiple sclerosis (RMS) or......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
